Maseda, Emilio
Grau, Santiago
Luque, Sonia
Castillo-Mafla, Maria-Pilar
Suárez-de-la-Rica, Alejandro
Montero-Feijoo, Ana
Salgado, Patricia
Gimenez, Maria-Jose
García-Bernedo, Carlos A.
Gilsanz, Fernando
Roberts, Jason A.
Funding for this research was provided by:
Astellas Pharma
Article History
Received: 25 January 2018
Accepted: 26 March 2018
First Online: 15 April 2018
Ethics approval and consent to participate
: The study protocol was approved by the Ethics Committee of Hospital La Paz (Madrid, Spain) and Hospital del Mar (Barcelona, Spain). Written informed consent was obtained from patients (or relatives if the patient was unable to provide due to their critical situation) before blood sampling.
: EM has received consultancy fees and payment for lectures from Astellas Pharma S.A. (Madrid, Spain), Pfizer, Novartis, Angellini, and Merck Sharp and Dohme. SG has received grants for research from Astellas Pharma S.A. (Madrid, Spain), Pfizer, Roche Pharma, and Angelini Pharma, and funds for speaking at symposia organized by Pfizer, Astellas Pharma S.A., and Merck Sharp and Dohme. SL has received travel grants from Astellas Pharma for medical conference attendance. CAG-B has received travel grants from Astellas Pharma for Sepsis Valladolid 2014 Congress attendance. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.